Collectively, results presented in this study provide novel insights into pathways that restrict ERα signaling and metastatic progression of ERα+ breast cancer, which potentially involves luminal to luminal/basal hybrid conversion due to an aberrant DR pathway. The gene discussed is ESR1; the disease is breast carcinoma.